Arrowhead Pharmaceuticals (ARWR) Earnings Date, Estimates & Call Transcripts → A Silent Invasion of America (From The Freeport Society) (Ad) Free ARWR Stock Alerts $25.84 -0.66 (-2.49%) (As of 06/14/2024 ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Earnings SummaryUpcoming Earnings DateAug. 5EstimatedActual EPS (May. 9) -$1.02 Missed By -$0.96 Consensus EPS (May. 9) -$0.06 Read Call TranscriptListen to Call Get Arrowhead Pharmaceuticals Earnings AlertsEnter your email address below to receive the latest news and earnings results for ARWR and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueARWR Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.ARWR Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad The Freeport SocietyA Silent Invasion of AmericaThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern border is a travesty, but the 'invasion' I've found will have 10 times greater effects on our economy, and ultimately our way of life.Go here to see why. Arrowhead Pharmaceuticals Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany GuidanceQ1 20243($1.00)($0.29)($0.62) Q2 20244($1.17)($0.24)($0.59) Q3 20244($0.64)($0.24)($0.50) Q4 20244($0.95)$0.31($0.54) FY 202415($3.76)($0.46)($2.25) Q1 20251($0.70)($0.70)($0.70) Q2 20251($0.70)($0.70)($0.70) Q3 20251($0.67)($0.67)($0.67) Q4 20251($0.61)($0.61)($0.61) FY 20254($2.68)($2.68) ($2.68)ARWR Earnings Date and InformationArrowhead Pharmaceuticals last released its earnings data on May 9th, 2024. The biotechnology company reported ($1.02) earnings per share for the quarter, missing analysts' consensus estimates of ($0.06) by $0.96. Its quarterly revenue was down 100.0% on a year-over-year basis. Arrowhead Pharmaceuticals has generated ($4.25) earnings per share over the last year (($4.25) diluted earnings per share). Earnings for Arrowhead Pharmaceuticals are expected to grow in the coming year, from ($3.05) to ($2.71) per share. Arrowhead Pharmaceuticals has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, August 5th, 2024 based off prior year's report dates.Read More Arrowhead Pharmaceuticals Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 8/5/2024(Estimated)------- 5/9/2024Q2 2024($0.06)($1.02)($0.96)($1.02)$41.97 million- 2/6/2024Q1 2024($0.78)($1.24)($0.46)($1.24)$35.60 million$3.55 million 11/29/2023Q4 2023($0.70)($1.03)($0.33)($1.03)$38.87 million$16.10 million8/7/2023Q3 2023($0.58)($0.96)($0.38)($0.96)$45.42 million$15.83 million 5/2/2023Q2 2023($0.65)$0.45+$1.10$0.45$45.48 million$146.27 million 2/6/2023Q4 2022$1.14($0.39)($1.53)($0.39)$162.52 million$62.55 million Get the Latest News and Ratings for ARWR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Arrowhead Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 11/28/2022Q4 2022($0.57)($0.81)($0.24)($0.81)$107.60 million$31.58 million8/4/2022Q3 2022($0.45)($0.68)($0.23)($0.68)$52.61 million$32.41 million 5/10/2022Q2 2022$0.39$0.41+$0.02$0.41$122.15 million$151.80 million 2/2/2022Q1 2022($0.22)($0.60)($0.38)($0.60)$67.30 million$27.44 million 11/22/2021Q3 2021$0.04($0.61)($0.65)($0.61)$79.31 million$38.28 million 8/4/2021Q2 2021($0.08)($0.29)($0.21)($0.29)$50.20 million$45.89 million 5/3/2021Q1 2021($0.09)($0.26)($0.17)($0.26)$39.42 million$32.81 million 2/3/2021Q4 2020$1.00($0.20)($1.20)($0.20)$157.48 million$21.30 million 11/22/2020Q3 2020$0.34($0.48)($0.82)($0.48)$85.13 million$7.63 million 8/5/2020Q2 2020($0.07)($0.13)($0.06)($0.13)$38.76 million$27.38 million 5/7/2020Q1 2020($0.11)($0.20)($0.09)($0.20)$21.90 million$23.53 million 2/5/2020Q4 2019$0.04($0.03)($0.07)($0.03)$36.63 million$29.46 million 11/25/2019Q4$0.14$0.11($0.03)$0.11$36.97 million$43.29 million 8/5/2019Q3 2019$0.34$0.21($0.13)$0.21$59.05 million$42.70 million Arrowhead Pharmaceuticals Earnings - Frequently Asked Questions When is Arrowhead Pharmaceuticals's earnings date? Arrowhead Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, August 5th, 2024 based off last year's report dates. Learn more on ARWR's earnings history. Did Arrowhead Pharmaceuticals beat their earnings estimates last quarter? In the previous quarter, Arrowhead Pharmaceuticals (NASDAQ:ARWR) missed the analysts' consensus estimate of ($0.06) by $0.96 with a reported earnings per share (EPS) of ($1.02). Learn more on analysts' earnings estimate vs. ARWR's actual earnings. How can I listen to Arrowhead Pharmaceuticals's earnings conference call? The conference call for Arrowhead Pharmaceuticals's latest earnings report can be listened to online. Listen to Conference Call How can I read Arrowhead Pharmaceuticals's conference call transcript? The conference call transcript for Arrowhead Pharmaceuticals's latest earnings report can be read online. Read Transcript How much revenue does Arrowhead Pharmaceuticals generate each year? Arrowhead Pharmaceuticals (NASDAQ:ARWR) has a recorded annual revenue of $240.74 million. How much profit does Arrowhead Pharmaceuticals generate each year? Arrowhead Pharmaceuticals (NASDAQ:ARWR) has a recorded net income of -$205.27 million. ARWR has generated -$4.25 earnings per share over the last four quarters. What is Arrowhead Pharmaceuticals's EPS forecast for next year? Arrowhead Pharmaceuticals's earnings are expected to grow from ($3.05) per share to ($2.71) per share in the next year. More Earnings Resources from MarketBeat Related Companies: ACAD Earnings Results BHC Earnings Results SRPT Earnings Results CTLT Earnings Results ELAN Earnings Results INSM Earnings Results ROIV Earnings Results LEGN Earnings Results ASND Earnings Results CERE Earnings Results Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Apple Stock All-Time Highs: Can AI Outweigh Earnings Jitters?CrowdStrike's Earnings: Consolidation and AI-Driven Growth The Most Upgraded Stocks After the Q1 Earnings Season ZIM Shipping Stock Forecast, Earnings Triggers a BuyAmerican Superconductor's Earnings Surge, Future Growth ExpectedHormel: A Potential Buy Despite Post-Earnings DeclineCanopy Growth’s Earnings: Profitability Despite Industry Shifts This page (NASDAQ:ARWR) was last updated on 6/16/2024 by MarketBeat.com Staff From Our PartnersTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredThe Only Energy Play You Should Be Looking AtOpen AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has alr...Wealthpin Pro | SponsoredHurry! Buy this stock before the Robinhood traders do!Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | SponsoredBreaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | SponsoredThe attacks will come for me after releasing this…America’s “Internal Enemies” Exposed New documentary exposes a hidden election plan in Washington D.C. that...Porter & Company | SponsoredThe #1 Crypto That You Don’t Own… YetThere’s all kinds of “signals” to follow when investing in cryptos. But there’s one signal you should pay a...Crypto 101 Media | SponsoredBUY ALERT: Tiny tech play partners with US governmentThe Federal Reserve is rolling out a powerful new financial technology across the entire U.S. banking system. ...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Arrowhead Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Arrowhead Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.